Maryland weighs new approach to curbing prescription drug costs
The bill’s goal is to rein in the skyrocketing cost of pharmaceuticals without running afoul of U.S. patent law, which allows drugmakers to hold a monopoly and pricing advantage for years after they patent a new medication. Federal courts struck down a D.C. drug-affordability law passed in 2005, which …